Table 1.
Baseline characteristics
| Characteristics | Treatment group (n = 69) | Control group (n = 73) | P value |
|---|---|---|---|
| Age | 65.8 ± 11.0 | 66.6 ± 12.7 | 0.857 |
| Male, n (%) | 45 (65.2%) | 44 (60.2%) | 0.741 |
| Hypertension, n (%) | 53 (76.8%) | 44 (60.2%) | 0.258 |
| Diabetes, n (%) | 19 (24.6%) | 19 (27.3%) | 0.894 |
| Coronary heart disease, n (%) | 8 (11.5%) | 11 (15.1%) | 0.815 |
| Atrial fibrillation, n (%) | 20 (28.9%) | 23 (31.5%) | 0.874 |
| Smoking, n (%) | 22 (31.9%) | 25 (34.2%) | 0.852 |
| Alcohol consumption, n (%) | 14 (20.2%) | 15 (20.5%) | 0.926 |
| Stroke history, n (%) | 11 (15.9%) | 21 (28.7%) | 0.512 |
| Internal carotid artery occlusion, n (%) | 26 (37.7%) | 20 (27.4%) | 0.428 |
| Middle cerebral artery occlusion, n (%) | 39 (56.5%) | 48 (65.7%) | 0.365 |
| Internal carotid artery + middle cerebral artery occlusion, n (%) | 4 (5.8%) | 4 (5.5%) | 0.999 |
| Thrombolysis, n (%) | 22 (31.9%) | 20 (27.3%) | 0.682 |
| Thrombectomy, n (%) | 39 (56.5%) | 40 (54.8%) | 0.903 |
| NIHSS score at admission | 10.0 ± 6.1 | 10.6 ± 6.4 | 0.952 |
| mRS score at admission | 3.9 ± 1.3 | 4.0 ± 1.2 | 0.935 |